top of page

NEWS & BLOGS
Blog: Blog2


FDA approves new drug to improve heart function in adults with rare heart condition
Apr 29 2022 FDA has approved Camzyos (mavacamten) capsules to treat adults with symptomatic New York Heart Association (NYHA)External...
Provision Consulting Group
Apr 29, 20222 min read


At-Home COVID-19 Diagnostic Tests Q&A
Apr 28 2022 At-home COVID-19 tests safety FDA authorized at-home COVID-19 tests are safe to use when people follow the manufacturer’s...
Provision Consulting Group
Apr 28, 20225 min read


FDA Approves First COVID-19 Treatment for Young Children
Apr 27 2022 Today, the U.S. Food and Drug Administration expanded the approval of the COVID-19 treatment Veklury (remdesivir) to include...
Provision Consulting Group
Apr 27, 20222 min read


FDA, OTC Medical Devices Q&A for Device Manufacturers
Apr 20 2022 Over-the-counter (OTC) medical devices are those that may be offered for sale directly to the consumer. In other words, these...
Provision Consulting Group
Apr 20, 20228 min read


FDA, OTC skin lightening products
Apr 19 2022 FDA issued warning letters to 12 companies for selling over-the-counter (OTC) skin lightening products containing...
Provision Consulting Group
Apr 19, 20223 min read


FDA Authorizes First COVID-19 Diagnostic Test Using Breath Samples
Apr 14 2022 Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first COVID-19 diagnostic...
Provision Consulting Group
Apr 14, 20222 min read


How to prepare a De Novo Request?
Apr 12 2022 In the United States, successfully launching a product is as important as developing a new medical device. Let's take a look...
Provision Consulting Group
Apr 13, 20223 min read


In Vitro Diagnostics EUAs - Antigen Diagnostic Tests for SARS-CoV-2
Apr 08 2022 Individual EUAs for Antigen Diagnostic Tests for SARS-CoV-2 This table includes information about authorized SARS-CoV-2...
Provision Consulting Group
Apr 8, 20222 min read


FDA approves alpelisib for PIK3CA-related overgrowth spectrum
Apr 06 2022 On April 5, 2022, the Food and Drug Administration granted accelerated approval to alpelisib (Vijoice, Novartis...
Provision Consulting Group
Apr 8, 20222 min read


FDA updates Sotrovimab emergency use authorization
Apr 05 2022 Update [4/5/2022] Sotrovimab is no longer authorized to treat COVID-19 in any U.S. region due to increases in the proportion...
Provision Consulting Group
Apr 5, 20222 min read
bottom of page
.png)